Docetaxel API

Docetaxel API

CAS Number:

154229-18-2

Category:

Anti-Cancer

Grades:

IP/BP/USP

Contact for Order

Description:

Kelar Pharmachem India is a trusted manufacturer and exporter of Docetaxel API, supplying high-quality oncology APIs to pharmaceutical companies across 40+ global markets. Docetaxel is a taxane-class anticancer agent widely used in the treatment of breast cancer, prostate cancer, non-small cell lung cancer (NSCLC), gastric cancer, and head and neck cancers, making it a critical molecule in sterile injectable oncology formulations.

Recognized internationally among reliable Docetaxel API manufacturers, Kelar Pharmachem India delivers APIs with high assay purity, stringent impurity control, excellent stability, and consistent batch-to-batch performance. Our expertise in complex cytotoxic and oncology molecules positions us as a dependable bulk Docetaxel API supplier from India.

Quality Standards and Regulatory Compliance

Our oncology API manufacturing facilities operate in alignment with globally accepted pharmaceutical regulations, including:

  • DCGI

  • WHO-GMP

  • US-FDA aligned systems

  • cGMP guidelines

These systems ensure validated synthesis processes, tight impurity profiling, moisture and stability control, and full pharmacopeial compliance for Docetaxel API intended for regulated and semi-regulated markets.

Global Export Capabilities

Kelar Pharmachem India exports Docetaxel API from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions. We support formulation manufacturers producing life-saving anticancer injectables through reliable supply, consistent quality, and comprehensive regulatory documentation.

End-to-End Oncology API Expertise

As a specialized producer of Active Pharmaceutical Ingredients and Intermediates, Kelar Pharmachem India manages the complete lifecycle of oncology API development. This includes process research and development, complex oncology synthesis, commercial-scale manufacturing, HPAPI capabilities, quality assurance, and worldwide distribution.

Our integrated manufacturing approach ensures long-term supply reliability and compliance with global quality expectations.

International Market Presence

Kelar Pharmachem India has established a strong presence across regulated and emerging pharmaceutical markets worldwide. Our expanding international footprint reflects our commitment to quality-driven manufacturing, regulatory alignment, and responsible global supply of oncology APIs.

Scroll to Top